Erickson Lori A.
Endocr Pathol. 2000 Summer;11(2):109-122. doi: 10.1385/ep:11:2:109.
Endocrine tumors are often diagnostic challenges. Recent studies have suggested that proteins that regulate cell cycle may have diagnostic and prognostic utility in endocrine tumors. p27(kip1) (p27) is a cyclin-dependent kinase inhibitor that regulates the transition from the G1 to the S phase of the cell cycle. p27 and other cell-cycle proteins are becoming increasingly important in assessing the biologic behavior of endocrine neoplasms, classifying hyperplastic and neoplastic endocrine tissues, and in the progression of endocrine tumors. p27 appears to separate normal from neoplastic endocrine tissues and, in some cases, benign from malignant endocrine tumors. However, there is overlap in p27 expression among individual cases of benign and malignant tumors, and p27 has only limited prognostic utility in endocrine tumors compared to some epithelial tumors such as breast and prostate neoplasms. Thus, more effective molecular and cellular markers that can be used for diagnostic and prognostic purposes in endocrine pathology are needed.
内分泌肿瘤常常是诊断上的难题。最近的研究表明,调节细胞周期的蛋白质可能在内分泌肿瘤的诊断和预后评估中具有实用价值。p27(kip1)(p27)是一种细胞周期蛋白依赖性激酶抑制剂,可调节细胞周期从G1期到S期的转换。p27和其他细胞周期蛋白在评估内分泌肿瘤的生物学行为、对增生性和肿瘤性内分泌组织进行分类以及内分泌肿瘤的进展过程中变得越来越重要。p27似乎能够区分正常与肿瘤性内分泌组织,在某些情况下,还能区分良性与恶性内分泌肿瘤。然而,在良性和恶性肿瘤的个别病例中,p27表达存在重叠,并且与一些上皮性肿瘤(如乳腺和前列腺肿瘤)相比,p27在内分泌肿瘤中的预后实用价值有限。因此,需要更有效的分子和细胞标志物用于内分泌病理学的诊断和预后评估。